These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24858300)

  • 1. Isolation and structure characterization of related impurities in etimicin intermediate P1 by LC/ESI-MS(n) and NMR.
    Wang Y; Zhang Z; Wu L; Zhang X; Wang H; Ye W; Li P
    J Pharm Biomed Anal; 2014 Aug; 97():97-102. PubMed ID: 24858300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and structure characterization of related impurities in etimicin sulfate by LC/ESI-MS(n) and NMR.
    Wang H; Zhang Z; Xiong F; Wu L; Li P; Ye W
    J Pharm Biomed Anal; 2011 Jul; 55(5):902-7. PubMed ID: 21444173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry.
    Grahek R; Zupancic-Kralj L
    J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast determination of underivatized gentamicin C components and impurities by LC-MS using a porous graphitic carbon stationary phase.
    Rodriquez M; Cretoso DS; Euterpio MA; Russo P; Crescenzi C; Aquino RP
    Anal Bioanal Chem; 2015 Oct; 407(25):7691-701. PubMed ID: 26282486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structure characterization of related impurities in Sodium Tanshinone IIA Sulfonate by LC/ESI-MS(n) and NMR.
    Wang B; Wang H; Wang E; Yan W; Ye W; Li P
    J Pharm Biomed Anal; 2012; 67-68():36-41. PubMed ID: 22591803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity profiling of etimicin sulfate by liquid chromatography ion-trap mass spectrometry.
    Yuan YZ; Zhang M; Fan XL; Wang GH; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2012 Nov; 70():212-23. PubMed ID: 22819209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of liquid chromatography tandem mass spectrometry methods for the determination of gentamicin, lincomycin, and spectinomycin in the presence of their impurities in pharmaceutical formulations.
    Vučićević-Prčetić K; Cservenák R; Radulović N
    J Pharm Biomed Anal; 2011 Dec; 56(4):736-42. PubMed ID: 21839597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparative purification of gentamicin components using high-speed counter-current chromatography coupled with electrospray mass spectrometry.
    Inoue K; Hattori Y; Horie M; Hino T; Oka H
    J Sep Sci; 2011 Jun; 34(12):1484-8. PubMed ID: 21548130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of impurities in vertilmicin sulfate by liquid chromatography ion-trap mass spectrometry.
    Yuan YZ; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jun; 80():1-8. PubMed ID: 23518304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B; Sharma BA; Mahale G; Singh D; Kumar A
    J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.
    Chen ZH; Zhou H; Wang S; Li G; Zhang J; Wang F; Li C; Qiao RZ
    Pharmazie; 2019 Jun; 74(6):352-356. PubMed ID: 31138373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of fluorescent labeled gentamicin as biological tracer and its characterization by liquid chromatography and high resolution mass spectrometry.
    Woiwode U; Sievers-Engler A; Lämmerhofer M
    J Pharm Biomed Anal; 2016 Mar; 121():307-315. PubMed ID: 26775580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
    Kumar N; Devineni SR; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling of micronomicin sulfate injection by liquid chromatography-ion trap mass spectrometry.
    Yuan YZ; Zhao X; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():94-104. PubMed ID: 23261805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.